KenSci

Seattle, United States Founded: 2015 • Age: 11 yrs Acquired By Tegria
Machine learning-based predictive analytics platform for healthcare risk prediction.

About KenSci

KenSci is a Healthcare company based in Seattle (United States) founded in 2015, and was acquired by Tegria in June 2021. Machine learning-based predictive analytics platform for healthcare risk prediction. It operates in the Healthcare and Technology sectors. KenSci has raised $30.5 million across 3 funding rounds from investors including Underwriters Laboratories, Tegria and Polaris Partners. Its Indian entity Kensci Tech India Private Limited reported revenue of β‚Ή2.51 Cr. Its focus areas include HealthTech, Healthcare IT, Provider and Administrative Solutions. Its competitors include Strata Decision, Provide and Heard; 1 of its 3 listed competitors has raised funding.

Company details

KenSci provides machine learning based predictive analytics platform for healthcare providers. The platform predicts who might get sick, how sick might they get and the most effective way to care for them. The platform is engineered to ingest, transform, and clean healthcare data across clinical, claims and patient generated sources. The KenSci model bank selects from 200 healthcare specific machine learning models developed on over very large (10M rows) data sets to provide statistically significant outcomes. The company is a part of the fourth class Microsofts Accelerator.

Key Metrics
  • Indian entity revenue
    ₹2.51 Cr

    FY 2019 · -9% YoY

  • Indian entity net profit
    ₹24.1 Lakh

    FY 2019 · 10% margin

  • Indian entity EBITDA
    ₹32.8 Lakh

    FY 2019 · 13% margin

  • Total Equity Funding
    $30.5M (USD)

    in 3 rounds

  • Latest Funding Round
    $22M (USD), Series B

    Feb 2019

  • Investors
  • Acquired by
    Tegria

    (Jun 2021)

Funding Insights of KenSci

KenSci has successfully raised a total of $30.5M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $22 million completed in February 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $30.5M
  • Total Rounds 3
  • Last Round Series B β€” $22M
  • First Round $8.5M

    (Jan 2017)

  • Investors Count 5

All 3 funding rounds of KenSci with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2019$22MSeries B–Polaris Partners
Jun 2018Grant––
–
Jan 2017$8.5MSeries A–Ignition Partners
Valuation history

6 investors in total: 6 institutional.

Investors in KenSci

KenSci has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Underwriters Laboratories, Tegria and Polaris Partners.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
US focused venture capital firm
polarispartners.comBoston, United States
Early-stage technology investments are facilitated by Mindset Ventures.
mindset.venturesMountain View, United States
Early- to growth-stage startups are targeted for venture capital investments.
oup.vcBala Cynwyd, United States
Investments in enterprise software sectors are made by Ignition Partners.
ignition.vcLos Altos, United States
Safety testing and compliance services are provided for multiple industries.
1894ul.comNorthbrook, United States
Tegria | Healthcare Consulting & Technology Services
2020tegria.comUnited States
Premium access

Investor details for KenSci

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Kensci Tech India Private Limited (KenSci)

Kensci Tech India Private Limited is the primary company behind KenSci. The board of Kensci Tech India Private Limited currently have 3 directors; the longest-serving is Ankur Mukund Teredesai, appointed in 2017. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Ankur Mukund Teredesai
DIN 07825430
Director17 Jul 20179 yrs 3 moKensci Tech India Private Limited
Samir Bhalchandra Manjure
DIN 07825453
Director17 Jul 20179 yrs 3 moKensci Tech India Private Limited
Sivannarayana Mandava
DIN 08228182
Director19 Sep 20188 yrs 1 moKensci Tech India Private Limited

People of KenSci

19 people are tracked at KenSci (3 in leadership, 16 in team).

NameRoleGroup
Thomas G.
Director And Technical Program ManagerLeadership
Tyler Erickson
Senior Director, Client ServicesLeadership
Scott Woehl
VP Of RPA And BILeadership
Jane Scaramuzzi
Software EngineerTeam
Nicholas Cardin
Associate EngineerTeam
Matthew Hamilton
Manager, OperationsTeam
Chris Mascia
Senior QA EngineerTeam
Anthony Clark
RPA DeveloperTeam
Drew Grassi
Support EngineerTeam
Jake Richards
QA EngineerTeam
Priya Singh
Business ManagerTeam
Dylan Potts
Senior Software EngineerTeam
Carolyn Tuttle
Senior Manager Client SuccessTeam
Richa Jain
Senior Data ScientistTeam
Yiming G.
Data ScientistTeam
Kristin Connolly
Customer Success ManagerTeam
Aaron Hart
Senior Software EngineerTeam
Brandon Vestal
Senior Solutions EngineerTeam
Zoey Zhuang
Data ScientistTeam
Premium access

Complete people profiles for KenSci

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of KenSci

Figures of Kensci Tech India Private Limited, the primary company behind KenSci, for FY 2019. Revenue was ₹2.51 Cr (-9% year on year). Net profit was ₹24.1 Lakh (10% margin). EBITDA was ₹32.8 Lakh (13% margin).

  • ₹2.51 CrRevenue · FY 2019 · -9% YoY
  • ₹24.1 LakhNet profit · 10% margin
  • ₹32.8 LakhEBITDA · 13% margin
  • ₹1 LakhPaid-up capital

Balance sheet, profit and loss, cash flow and ratios of Kensci Tech India Private Limited are on its company page.

Premium access

Detailed financial statements for KenSci

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of KenSci

4 dated milestones of KenSci across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded KenSci is founded.
  2. Funding First funding round of $8.5M.
  3. Funding Latest funding round, Series B, of $22.0M.
  4. Exit Acquired by Tegria.

Competitors of KenSci

KenSci has 3 listed competitors in our database, 1 of them funded. They include Strata Decision, Provide and Heard.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
stratadecision.com1996Chicago, United States
Cloud-based financial analytics platform is provided to healthcare providers.
getprovide.com2014San Francisco, United States83
Financial management software is provided for healthcare professionals.
joinheard.com2019San Francisco, United States$26.3M
SaaS financial workflow software is offered for therapists.
Premium access

Detailed competitors of KenSci

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Clinical IT & Data Platforms

3 companies that operate in the same segment as KenSci (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M1,746
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Kensci

Premium access

Complete news archive for KenSci

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about KenSci

KenSci was founded in 2015 and raised its 1st funding round 2 years after it was founded.

KenSci is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.

KenSci is a funded company, having raised a total of $30.5M across 3 funding rounds to date. The company's 1st funding round was a Series A of $8.5M, raised on Jan 2017.

The primary company behind KenSci, Kensci Tech India Private Limited, reported revenue of β‚Ή2.51 Cr for FY 2019, down 9% year on year.

KenSci provides machine learning based predictive analytics platform for healthcare providers. The platform predicts who might get sick, how sick might they get and the most effective way to care for them. The platform is engineered to ingest, transform, and clean healthcare data across clinical, claims and patient generated sources. The KenSci model bank selects from 200 healthcare specific machine learning models developed on over very large (10M rows) data sets to provide statistically significant outcomes. The company is a part of the fourth class Microsofts Accelerator.

KenSci's top competitors include Strata Decision, Heard and Provide.

KenSci has 6 investors. Key investors include Underwriters Laboratories, Tegria, Polaris Partners, Mindset Ventures, and Osage University Partners.

KenSci operates through Kensci Tech India Private Limited.

Yes. KenSci was acquired by Tegria in June 2021.

The legal entities of KenSci currently have 3 directors, including Ankur Mukund Teredesai, Samir Bhalchandra Manjure, Sivannarayana Mandava.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available